Coty Inc. sees opportunities to grow its business in the $24bn prestige female fragrance market and strengthen its play in the ‘ultra-premium’ segment. The firm’s prestige fragrance sales rose 20% like-for-like in the fiscal 2023 fourth quarter ended 30 June, fueling overall net sales growth of 10% for the period.
Already a leader in prestige fragrance globally, Coty, Inc. continues to pursue “immense” growth opportunities, including prestige fragrances for women and ultra-premium scents.
“We still have ample white space opportunities in this category, even within our stronghold geographies,” CEO Sue Nabi said in...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
